Postoperative Hypofractionated Intensity-modulated Radiation Therapy in Cervical Cancer

Clinical trial NCT03239626 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03239626
Sponsor: Samsung Medical Center
Status: ACTIVE_NOT_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Cervix Cancer Radiotherapy, Adjuvant Radiotherapy, Intensity-Modulated Hypofractionated Dose

Start date: 2017-08-31
Primary completion: 2025-04-28
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.